Key Drivers
- Profit rebound
- Margin expansion
- Debt burden
AIAI Summary
ACHC has shifted from a “cheap but losing” story to a credible turnaround, with same-facility growth, margin rebound, and positive free cash flow suggesting the business is inflecting, but investors should treat it as a hold-for-proof name until it can sustain profits, cash generation, and a decisive break above the 27–28 resistance zone amid ongoing regulatory and reimbursement risk.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profit rebound
- •Margin expansion
- •Debt burden
ACHC posted a sharp Q1 2026 turnaround in profitability and free cash flow, but elevated leverage and a large intangible asset base still make the recovery fragile.
Price Behavior
Key Price Behavior Insights:
- •Mid-$24 support
- •Failed breakout
- •Momentum cooling
ACHC is in a mixed-to-bearish short-term setup: buyers are defending the mid-$24s, but repeated failures to hold the $27-$28 area show fading momentum and a cautious near-term bias.
Rebounded from $24.46 to $27.15, then quickly faded after failing at resistance
Sentiment & News
Key News Insights:
- •Revenue Growth
- •Cost Pressure
- •CFO Transition
Acadia delivered a Q1 earnings and revenue beat with improving volume trends, but ongoing cost, payer-mix, leadership, and valuation concerns still cloud the stock.
ACHC's stronger near-term operating momentum supports the shares, but persistent structural risks could limit sustained upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings